GSE192362 erastin 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE192362_erastin_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE192362_erastin_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE192362_erastin_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE192362_erastin_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

NmrA like redox sensor 2, pseudogene

Gene

ELFN1 antisense RNA 1

Gene

TXNRD1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 520

Gene

TNFRSF10A divergent transcript

Gene

RUNX1 antisense RNA 1

Gene

lung cancer associated lncRNA 1

Gene

PDE7B antisense RNA 1

Gene

olfactory receptor family 7 subfamily E member 14 pseudogene

Gene

long intergenic non-protein coding RNA 2688

  • Gene

    NmrA like redox sensor 2, pseudogene


  • Gene

    ELFN1 antisense RNA 1


  • Gene

    TXNRD1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 520


  • Gene

    TNFRSF10A divergent transcript


  • Gene

    RUNX1 antisense RNA 1


  • Gene

    lung cancer associated lncRNA 1


  • Gene

    PDE7B antisense RNA 1


  • Gene

    olfactory receptor family 7 subfamily E member 14 pseudogene


  • Gene

    long intergenic non-protein coding RNA 2688

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.